Q2 2026 Holdings
Filed 2026-08-14 | 57 holdings | $1.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Natera Inc(NTRA) | COM | 632307104 | $420.8M | 1,550,280 | 21.8% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $119.9M | 2,793,987 | 6.2% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $111.1M | 4,045,215 | 5.7% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $88.0M | 365,341 | 4.6% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $79.4M | 1,904,408 | 4.1% |
| Seaport Therapeutics Inc(SPTX) | COM | 81221K108 | $77.4M | 3,564,871 | 4.0% |
| Arrivent BioPharma Inc(AVBP) | COM | 04272N102 | $58.9M | 1,696,752 | 3.0% |
| Ultragenyx Pharmaceutical In(RARE) | COM | 90400D108 | $57.3M | 1,717,505 | 3.0% |
| BioAge Labs Inc(BIOA) | COM | 09077V100 | $56.2M | 2,293,788 | 2.9% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $50.5M | 876,970 | 2.6% |
| Supernus Pharmaceuticals(SUPN) | COM | 868459108 | $48.2M | 1,036,328 | 2.5% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $45.3M | 408,027 | 2.3% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $43.3M | 343,100 | 2.2% |
| United Therapeutics Corp Del(UTHR) | COM | 91307C102 | $41.4M | 76,489 | 2.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $40.1M | 1,035,148 | 2.1% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $39.3M | 160,429 | 2.0% |
| Immatics N.v(IMTX) | SHS | N44445109 | $37.2M | 3,669,346 | 1.9% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $36.8M | 1,658,384 | 1.9% |
| Immunome Inc(IMNM) | COM | 45257U108 | $36.5M | 1,720,316 | 1.9% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $34.5M | 925,119 | 1.8% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $33.3M | 493,536 | 1.7% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $32.9M | 471,763 | 1.7% |
| Pharvaris N V(PHVS) | COM | N69605108 | $30.5M | 881,299 | 1.6% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $29.2M | 945,690 | 1.5% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $28.7M | 303,103 | 1.5% |
| BioMarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $20.5M | 358,568 | 1.1% |
| Veradermics Inc(MANE) | COMMON STOCK | 922967104 | $18.3M | 148,993 | 0.9% |
| Alcon AG(ALC) | ORD SHS | H01301128 | $17.2M | 255,824 | 0.9% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $16.9M | 158,398 | 0.9% |
| Ultragenyx Pharmaceutical In(RARE)Call | COM | 90400D108 | $16.7M | 500,000 | 0.9% |
| Intuitive Surgical Inc(ISRG)Call | COM NEW | 46120E602 | $15.9M | 40,000 | 0.8% |
| Globus Med Inc(GMED)Call | CL A | 379577208 | $15.8M | 200,000 | 0.8% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $15.5M | 380,923 | 0.8% |
| Exelixis Inc(EXEL)Put | COM | 30161Q104 | $13.8M | 254,200 | 0.7% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $12.7M | 524,098 | 0.7% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $12.5M | 865,135 | 0.6% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $12.0M | 255,903 | 0.6% |
| First Tracks Biotherapeutics(TRAX) | ORD SHS | 337185102 | $11.4M | 565,199 | 0.6% |
| Abbott Laboratories(ABT) | COM | 002824100 | $11.2M | 122,998 | 0.6% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $10.7M | 146,239 | 0.6% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $7.3M | 500,039 | 0.4% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $6.4M | 144,432 | 0.3% |
| Absci Corporation(ABSI) | COM | 00091E109 | $3.9M | 337,400 | 0.2% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $3.2M | 27,591 | 0.2% |
| Jade Biosciences Inc(JBIO) | COM | 008064206 | $2.4M | 107,391 | 0.1% |
| Savara Inc(SVRA) | COM | 805111101 | $2.2M | 364,763 | 0.1% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $2.2M | 6,440 | 0.1% |
| Septerna Inc(SEPN) | COM | 81734D104 | $1.6M | 47,506 | 0.1% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $1.5M | 321,692 | 0.1% |
| Sagimet Biosciences Inc(SGMT) | COM SER A | 786700104 | $1.3M | 166,667 | 0.1% |